Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions
Serena Omo‐Lamai(Translational Therapeutics (United States)), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Alina D. Peshkova(Kazan Federal University), Jacob W. Myerson(Translational Therapeutics (United States)), Liam S. Chase(University of Pennsylvania), Jia Nong(Translational Therapeutics (United States)), Oscar A. Marcos‐Contreras(Translational Therapeutics (United States)), Manthan N. Patel(Translational Therapeutics (United States)), Jichuan Wu(University of Pennsylvania), Zhicheng Wang(Central South University), Marco E. Zamora(Translational Therapeutics (United States)), Eno‐Obong Essien(Translational Therapeutics (United States))
Cited by 9
Related Papers
Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted Carriers
|Molecular Therapy|2008|566
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
|Molecular Therapy|2021|272
Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions
|Advanced Materials|2024|99
Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases
|Nature Biomedical Engineering|2020|92
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke
|Molecular Therapy|2024|83